RHOB and colitis: Decreased weight loss, diarrhea, rectal bleeding, and disease activity index (DAI, a composite score used to evaluate the clinical manifestations of colitis) were observed in DSS-treated RhoB+/− and RhoB−/− mice compared with those in DSS-treated WT mice (Fig. 2A–D).